Effect of aspirin in vascular surgery in patients from a randomized clinical trial (POISE-2).
Bruce M BiccardAlben SigamaniM T V ChanD I SesslerA KurzJ G TittleyT RapanosJ HarlockD SzalayM E TiboniE PopovaS M VásquezB KabonM AmirM MrkobradaB R MehraH El BeheiryE MataB TenaS SabatéM K Zainal AbidinV R ShahK BalasubramanianP J DevereauxPublished in: The British journal of surgery (2018)
This study suggests that the overall POISE-2 results apply to vascular surgery. Perioperative withdrawal of chronic aspirin therapy did not increase cardiovascular or vascular occlusive complications. Registration number: NCT01082874 ( http://www.clinicaltrials.gov).
Keyphrases
- minimally invasive
- low dose
- coronary artery bypass
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- cardiovascular events
- antiplatelet therapy
- peritoneal dialysis
- prognostic factors
- surgical site infection
- risk factors
- cardiovascular disease
- acute coronary syndrome
- percutaneous coronary intervention
- sickle cell disease
- patient reported outcomes
- cell therapy
- cone beam